The different surgical options for patients with colonic Crohn’s disease (CD) include segmental colectomy, subtotal colectomy or proctocolectomy with end ileostomy. We present a national, multicentre study, promoted by the Italian Society of Colorectal Surgery with the aim to collect benchmark data and national variations on multidisciplinary management and postoperative outcomes of patients undergoing surgery for colonic CD.
Methods
All adult patients having elective surgery for colonic CD from June 2018 to May 2019 were eligible for participation in this retrospective study. The primary outcome measure was postoperative morbidity within 30 days of surgery.
Results
One hundred twenty-two patients were included: 55 subtotal colectomy, 30 segmental colectomy, 25 proctectomy and 12 proctocolectomy. Eighty-six patients (70.4%) were discussed at the inflammatory bowel disease (IBD) multidisciplinary team meeting (MDT) prior to surgery. This ranged from 76.6% for segmental colectomy to 60% for subtotal colectomy, 66.6% for proctocolectomy and 48% for proctectomy. The proportion of patients counselled by a stoma nurse preoperatively was 50%. Laparoscopy was associated with reduced postoperative morbidity (p = 0.017) and shorter length of hospital stay (p < 0.001), whilst pre-operative anti-TNF was associated with Dindo-Clavien ≥ 3 complications (p = 0.023) and longer in-hospital stay (p = 0.007). The main procedure performed (segmental colectomy, subtotal colectomy, proctocolectomy or proctectomy) was not associated with postoperative morbidity (p = 0.626).
Conclusions
Surgery for colonic CD has a high rate of postoperative complications. Almost a third of the patients were not preoperatively discussed at the IBD MDT, whilst the use of minimally invasive surgery for surgical treatment of colonic CD ranges from 40 to 66%.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Introduction
Crohn’s disease (CD) is a chronic inflammatory condition that can affect any part of the gastrointestinal system, with one third of the patients having the disease confined to the large bowel [1]. There are different surgical options for patients with colonic CD, including segmental colectomy, subtotal colectomy with ileorectal anastomosis or total proctocolectomy with end ileostomy [2]. Surgical treatment of colonic CD can be challenging in view of the high risk of postoperative septic complications [3], the high rate of clinical and surgical recurrence and the impaired functional outcomes and quality of life that can result following extensive surgery. For this particular presentation of CD, a multidisciplinary management is of outmost importance [4], because evidence concerning the ideal surgical strategy is scarce. Moreover, differently from ulcerative colitis, surgical treatment of colonic CD comprises less extensive alternatives to proctocolectomy.
The most recent guidance on surgical treatment of inflammatory bowel diseases (IBD) of the Association of Coloproctologists of Great Britain and Ireland (ACPGBI) suggested that a segmental or subtotal colectomy and ileorectal anastomosis are both viable bowel-preserving options in case of isolated segmental colonic CD [5]. A recent meta-analysis concluded that segmental, subtotal and proctocolectomy can be equally effective in patients with colonic CD, but the quality of the included studies limits the external validity of the findings [6].
Anzeige
Of note, most studies do not consistently record key performance indicators of CD surgery, with paucity of audits on patient-reported outcome measures (PROMs) [7]. A limited number of studies have focused on postoperative complication in patients with colonic CD [8] with some being small case series over long period of times, or even before the availability of treatments with biologics [9, 10]. The aim of this study was to describe the management of colonic CD according to several quality indicators of postoperative outcome in patients included in a nationwide study promoted by the Italian Society of Colorectal Surgery (SICCR).
Methods
Study settings
In 2019, the Italian Society of Colorectal Surgery (SICCR) designed the retrospective, multicentre, snapshot study “Current Status of Crohn’s disease surgery”. The present STROBE [11] compliant study evaluates the treatment of colonic CD in Italy. Details have been previously reported [12]. Briefly, after developing the study protocol, which was approved by the SICCR research board, the steering committee invited Italian colorectal units to join the initiative via an open call and newsletters.
Ethical statement
Each local principal investigator (PI) was responsible for approval at the local ethical committee, and all participating centres obtained ethical approval. Informed consent was deemed not necessary (retrospective study) from the ethics committees.
Inclusion and exclusion criteria
All patients (aged 16 or older), who underwent elective surgery for colonic CD from 1 June 2018 to 31 May 2019, were evaluated. The following procedures were included: segmental colectomy, subtotal colectomy, proctocolectomy and proctectomy. If a right hemicolectomy was performed in the context of CD terminal ileitis this was excluded, as were patients having a concomitant segmental left colonic resection in the setting of penetrating ileitis. Patients having surgery for cancer, primary or recurrent CD of the distal ileum were excluded. The data collection period of 12 months was decided by the steering committee in order to collect a snapshot on the current status of CD surgery in Italy, to guide targeted quality improvement, where indicated. Patients were considered to have been treated with tumor necrosis factor (TNF)-alpha inhibitors if they had received infliximab infusion within the 4 weeks prior to surgery or adalimumab injection within 2 weeks prior the surgery. Immunosuppressor use was defined as azathioprine or methotrexate within 2 weeks from surgery, whilst an equivalent dose of 20 mg or more of prednisolone within one week of surgery was defined as steroids use.
Anzeige
Study endpoints and outcome measures
The primary endpoint consisted of postoperative morbidity within 30 days of surgery. Postoperative surgical site infections (SSIs) and use of laparoscopy were the secondary outcome measures.
Data collection and definitions
Collected data included baseline information and demographics, Montreal classification, preoperative medical treatment, indication for surgery, American Society of Anaesthesiologists (ASA) grade and operative details.
The following were used as key performance indicators:
Stoma rate, defined as the percentage of patients who received an intestinal stoma (both planned and unplanned, both temporary and definitive);
Surgical access and conversion rate;
Length of hospital stay (LOS), defined as duration of the stay from day of surgery to discharge;
30-day postoperative morbidity, as any complication occurring during the hospital stay or within 30 days of surgery;
SSIs within 30 days of surgery, defined as any superficial or deep septic complication related to the surgical site;
Readmissions and reoperations within 30 days from discharge;
Data on use of PROMs was also collected, as well as preoperative discussion in a dedicated multidisciplinary team meeting (MDT), preoperative consultation with a stoma care nurse and use of total parenteral nutrition (TPN). Data collection was responsibility of the local PI and was performed via the use of prospectively maintained databases, or retrieved using hospital coding registries.
Statistical analysis
Categorical variables are presented as frequency and percentages and were compared using the chi-square test or Fisher’s exact test, as appropriate. Continuous variables are presented as mean (± standard deviation) or median (range) according to their distribution and were compared with the use of Student’s t test or the Mann-Whitney U test in case of normal or skewed distribution, respectively. Uni- and multivariable logistic regression analyses were run in order to identify variables associated with binary outcomes. Clinically relevant variables with a p value equal to 0.10 or less at the univariate analysis were included in the multiple regression model. The odds ratio (ORs) with a 95% confidence interval (CI) was estimated as measure of association. All reported p values were two-tailed, and p values of less than 0.05 were considered to be statistically significant. Statistical analysis was performed by using IBM SPSS Statistics for Windows, version 25.0 (IBM Corp., Armonk, NY, USA).
Results
Overall, 144 patients treated in 20 hospitals were evaluated for inclusion. After excluding 17 patients undergoing urgent or emergency surgery and five patients who had ileostomy formation only, 122 patients were included in the analysis. Out of the included patients, 55 patients underwent subtotal colectomy (45.1%), 30 segmental colectomy (24.6%), 25 proctectomy (20.5%) and 12 proctocolectomy (9.8%). The procedures performed in the segmental colectomy group were as follows: 19 left hemicolectomies, 1 transverse colectomy, 5 Hartmann’s procedures and 5 anterior resections. In the subtotal colectomy group, 21 patients received an ileorectal anastomosis (38.2%). Every hospital was allocated a unique identifier number (ID). The number of total patients per hospital ranged from one to 32, as shown in Fig. 1. Baseline patients’ characteristics and preoperative medical treatments are detailed in Table 1.
Fig. 1
Number of surgical resections performed for colonic Crohn’s disease in the 20 participating hospitals
Table 1
Characteristics of the included patients
Segmental colectomy
Subtotal colectomy
Proctocolectomy
Proctectomy
p
Patients
30
55
12
25
M:F
14:16
23:32
7:5
12:13
0.761
Age
47 (28–79)
39 (17–83)
50 (24–76)
47 (22–77)
0.163†
BMI
22 (16–27)
21 (14–30)
24 (15.4–30)
24.5 (18–38)
0.006†
Recurrent disease
15 (50%)
24 (43.6%)
8 (66.6%)
20 (80%)
0.017
Montreal classification A
A1 11 (36.7%)
A2 12 (40%)
A3 7 (23.3%)
A1 11 (20%)
A2 27 (49.1%)
A3 17 (30.9%)
A1 2 (16.6%)
A2 2 (16.6%)
A3 8 (66.6%)
A1 1 (4%)
A2 8 (8%)
A3 14 (56%)
0.009
Montreal classification L
L2 19 (63.3%)
L3 11 (36.7%)
L2 30 (54.5%)
L3 25 (45.5%)
L2 4 (33.3%)
L3 8 (66.6%)
L2 17(68%)
L3 8 (32%)
0.136
Montreal classification B
B1 3 (10%)
B2 18 (60%)
B3 9 (30%)
B1 17 (30.9%)
B2 25 (45.5%)
B3 13 (23.6%)
B1 3 (25%)
B2 5 (41.7%)
B3 4 (33.3%)
B1 10 (40%)
B2 7 (28%)
B3 8 (32%)
0.429
Perianal disease
16 (53.3%)
23 (41.8%)
8 (66.6%)
18 (72%)
0.231
Previous abdominal surgery
16 (53.3%)
29 (52.7%)
6 (50%)
24 (96%)
0.001
MDT
23 (76.6%)
33 (60%)
8 (66.6%)
12 (48%)
0.169
USS
17 (56.6%)
29 (52.7%)
4 (33.3%)
8 (32%)
0.173
MRI
21 (70%)
35 (63.6%)
7 (58.3%)
19 (76%)
0.538
CT
24 (80%)
23 (41.8%)
7 (58.3%)
8 (32%)
<0.001
Capsule
0
1 (1.8%)
0
0
0.746
Stoma nurse
15 (50%)
22 (40%)
6 (50%)
9 (36%)
0.674
Dietitian
15 (50%)
17 (30.9%)
2 (16.6%)
2 (8%)
0.042
TPN
7 (23.3%)
8 (14.5%)
2 (16.6%)
2 (8%)
0.433
Steroids
11 (36.6%)
27 (49.1%)
4 (33.3%)
4 (16%)
0.043
Immunosupp
3 (10%)
7 (12.7%)
2 (16.6%)
2 (8%)
0.858
Anti-TNF
9 (30%)
16 (29.1%)
0
1 (4%)
0.010
M male, F female, BMI body mass index, Montreal classification A age at diagnosis, L location, B phenotype, MDT multidisciplinary team; USS ultrasound, MRI magnetic resonance imaging, CT computed tomography, TPN total parenteral nutrition, TNF tumor necrosis factor
p values are from Pearson’s chi square and from †one-way ANOVA
×
Multidisciplinary management and preoperative medical treatment
Eighty-six patients (70.4%) were discussed at the IBD MDT prior to surgery. This ranged from 76.6% for segmental colectomy to 60% for subtotal colectomy (p = 0.18), 66.6% for proctocolectomy (p = 0.62) and 48% for completion proctectomy (p = 0.04).
The proportion of patients counselled by a stoma nurse preoperatively was 50% in the segmental colectomy group, compared to 40% and 50% of subtotal colectomies and proctocolectomies, respectively. A higher number of patients were assessed by a dietitian and received preoperative TPN in the segmental colectomy group, as shown in Table 1.
Anzeige
Postoperative morbidity and length of stay
No 30-days post-operative mortality was reported. Overall morbidity within 30 days of surgery is shown in Table 2. Severe complications (Clavien-Dindo ≥ III), reoperations and readmissions were slightly more common following segmental colectomy compared to subtotal colectomy (Table 2) but this was not statistically significant. LOS ranged from 8 to 10 days (median 8.5 days, interquartile range 7–13). SSIs were the most common complications, with an incidence ranging from 8 to 27.3%.
Table 2
Surgical outcomes
Segmental colectomy
Subtotal colectomy
Proctocolectomy
Proctectomy
p
Patients
30
55
12
25
Stoma made
20 (66.6%)
36 (65.4%)
12 (100%)
25 (100%)
0.004
Lap approach
19 (63.3%)
34 (61.8%)
8 (66.6%)
11 (44%)
0.586
Conversion
3 (15.8%)
7 (20.6%)
2 (25%)
0
0.205
LOS
10 (4–34)
8 (4–66)
10 (4–26)
9 (2–34)
0.750†
Morbidity
11 (36.6%)
23 (41.8%)
5 (41.6%)
9 (36%)
0.416
SSIs
7 (23.3%)
15 (27.3%)
3 (25%)
2 (8%)
0.281
Dindo ≥ 3
4 (13.3%)
4 (7.3%)
1 (8.3%)
2 (8%)
0.902
Reoperations
4 (13.3%)
2 (3.6%)
1 (8.3%)
2 (8%)
0.055
Readmissions
4 (13.3%)
1 (1.8%)
0
0
0.520
LOS length of stay, SSIs surgical site infections, Lap laparoscopy
†p from one-way ANOVA
A subgroup analysis of the patients receiving an anastomosis without diversion between the segmental colectomy group (10 patients) and subtotal colectomy with ileorectal anastomosis group (19 patients) was performed. This revealed that 5 (50%) and 8 (42.1%) patients developed postoperative complications in the segmental colectomy and subtotal colectomy group respectively (p = 0.68), whilst severe complications (Clavien-Dindo ≥ III) occurred in 3 (30%) compared to 1 (5.2%) patients in the two groups (p = 0.07).
Laparoscopic surgery and conversion rate
There was no difference in the use of laparoscopic surgery between the included procedures (Table 2). There were no conversions to open surgery in patients undergoing completion proctectomy, whilst for segmental colectomies, subtotal colectomies and proctocolectomies, the conversion rate ranged from 15.8 to 25%.
Patient-reported outcome measures (PROMs)
There was a low adoption of standardised questionnaires to assess quality of life, bowel, urinary and sexual function following surgery for colonic CD, as these assessments were performed only in 5 patients (4%).
Anzeige
Univariate and multivariate analysis
At multivariate analysis, a laparoscopic approach (Table 3) was associated with reduced postoperative morbidity (p = 0.017) and shorter LOS (p < 0.001), whilst pre-operative administration of anti-TNF correlated with Dindo-Clavien ≥ III postoperative complications (p = 0.023) and longer LOS (p = 0.007). The use of preoperative TPN and anti-TNF was associated with postoperative SSIs at univariate analysis (Table 4). Surgery for recurrent CD was associated with conversion from a laparoscopic to an open approach (p = 0.029) and to SSIs (p = 0.042). The main procedure performed (segmental colectomy, subtotal colectomy, proctocolectomy or proctectomy) was not associated with postoperative morbidity (p = 0.626) or SSIs (p = 0.322).
Table 3
Univariate and multivariate analysis for postoperative morbidity in patients with colonic Crohn’s disease
Postoperative morbidity
Univariate analysis
Multivariate analysis
Variable
OR
95% CI
p
OR
95% CI
p
Age
1.016
0.992–1.04
0.193
Sex (female)
0.663
0.318–1.375
0.271
BMI
0.948
0.866–1.032
0.229
ASA grade ≥ 3
1.883
0.808–4.425
0.142
Recurrent CD
1.256
0.605–2.635
0.542
Main procedure
1.072
0.812–1.419
0.626
Montreal B = 3
2.045
0.919–4.591
0.080
1.357
0.527–3.490
0.527
Montreal L = 3
0.560
0.259–1.186
0.134
Perianal disease
0.927
0.454–1.888
0.834
Preoperative steroids
0.794
0.368–1.68
0.551
Preoperative immunosuppression
3.138
1.011–10.838
0.054
2.825
0.652–12.246
0.165
Preoperative anti-TNF
3.150
1.302–7.952
0.012
2.967
0.944–9.323
0.063
Preoperative TPN
1.127
0.405–3.029
0.813
Access (minimally invasive)
0.382
0.180–0.809
0.012
0.344
0.144–0.826
0.017
BMI body mass index, ASA American Society of Anaesthesiologists, OR odds ratio, CI confidence interval, TNF tumor necrosis factor, TPN total parenteral nutrition
Table 4
Univariate and multivariate analysis for postoperative surgical site infections (SSIs) in patients with colonic Crohn’s disease
Postoperative SSIs
Univariate analysis
Multivariate analysis
Variable
OR
95% CI
p
OR
95% CI
p
Age
0.99
0.97–1.02
0.613
Sex (female)
1.31
0.55–3.18
0.543
BMI
1.00
0.91–1.10
0.959
ASA grade ≥ 3
1.44
0.53–3.69
0.453
Recurrent CD
2.92
1.17–8.03
0.027
3.07
1.04–9.05
0.042
Main procedure
0.85
0.61–1.17
0.322
Montreal B = 3
1.98
0.79–4.84
0.137
Montreal L = 3
1.34
0.56–3.19
0.501
Perianal disease
1.01
0.44–2.34
0.983
Preoperative steroids
0.92
0.37–2.19
0.844
Preoperative immunosuppression
4.35
1.35–14.12
0.013
2.06
0.48–8.92
0.333
Preoperative anti-TNF
3.62
1.40–9.38
0.008
2.55
0.76–8.54
0.129
Preoperative TPN
4.20
1.48–11.96
0.007
2.95
0.91–9.60
0.072
Access (minimally invasive)
0.66
0.28–1.55
0.339
BMI body mass index, ASA American Society of Anaesthesiologists, OR odds ratio, CI confidence interval, TNF tumor necrosis factor, TPN total parenteral nutrition
Discussion
Our study confirms that surgery for colonic CD is affected by high postoperative morbidity, ranging from 36 to 41.8%, with SSIs representing the most frequent complication. Our study reported that approximately one-third of the patients undergoing segmental colectomy were on anti-TNF treatment, whilst up to half of the subtotal colectomies were currently on steroids. We found that anti-TNF treatment was associated with longer LOS and with severe postoperative morbidity (Dindo-Clavien ≥ 3), likely reflecting a selected group of patients compromised or with more complex disease, adding to the literature debate on the effect of biologics on surgical morbidity [13, 14]. Conversely, we did not demonstrate an increased complication rate for segmental resection compared to subtotal colectomy and proctocolectomy, which is considered to be up to a 2-fold increase as reported in a recent meta-analysis [6]. It is concerning that almost 30% of the patients did not receive preoperative input from the wider IBD MDT, with preoperative discussion ranging from 76% for segmental colectomies to 40% for proctectomies. Moreover, as surgical stoma was a common outcome of surgery for colonic CD (it was performed in 93 patients, 76.2%), it should be mandatory for patients to be counselled preoperatively by a dedicated stoma care team, whilst this only took place for 36 to 50% of the patients. Similarly, preoperative optimisation with TPN and input from the dietitians was more frequent in patients undergoing segmental resections. Prompt planning of elective surgery and high volume IBD surgeons may impact on bowel sparing surgery, preoperative medical treatment and postoperative outcomes when surgery is performed in specialist referral centres, with support from dedicated teams. Rather than expressing a particular preference for one surgical approach over the others, our results highlight the need for careful patient selection, preoperative optimisation and multidisciplinary input, to individualise the treatment according to extent of disease but also patients’ expectations and performance status, considering the high risk of postoperative complications and the known high recurrence rate of up to 65% for segmental resections [15].
We collected data on patients undergoing surgery during a 12 months period between 2018 and 2019 obtaining an up to date snapshot of the current status of surgery for colonic CD in Italy. Our results confirm the advantages of a minimally invasive approach for surgical treatment of colonic CD in terms of reduced postoperative morbidity and shorted LOS. However, we found a relatively low use of laparoscopic surgery, which ranged from 44 to 66% with a considerable conversion rate up to 25%.
Our study demonstrated significant heterogeneity across the 20 participating Italian hospitals in the number of cases performed per year, with 11 hospitals (55%) performing less than five procedures during the 12 months recruitment period. Rectal resection in CD can be particularly difficult in view of adhesions, inflammation and chronic pelvic abscesses, with possible implications on postoperative functional outcomes such as genitourinary function [16]. Of the 16 hospitals performing at least one procedure between completion proctectomy and proctocolectomy, only four (25%) performed at least three procedures per year, which could also reflect on the difficulties for surgeons in training to accumulate exposure to these complex procedures [17]. To reduce this variability, the SICCR recently published a national position statement with the aim to standardise multidisciplinary management and surgical treatment of CD nationally [18], and guidelines of several international societies have been released to optimize CD outcomes (e.g. European Crohn’s Colitis Organisation—ECCO [19], the American Society of Colorectal Surgery—ASCRS) [20]. A general aim of guidelines is to reduce variations in practice, by providing evidence based guidance on the best treatment options, with the aim to enhance patients’ outcomes.
Anzeige
Our study is limited by the small sample size, which may have underpowered the statistical analysis, and retrospective design with an intrinsic risk of recall and information bias. Many of the participating centres only included a small number of patients and SSIs and complication rates were directly reported by the operating surgeon, with variability in definitions [21] and high likelihood of selection bias. Moreover, our study focused on short term outcomes of surgery for colonic CD, without evaluating long term surgical recurrence, which should be the focus of prospective studies including mandatory PROMs evaluation.
Conclusions
Surgery for CD of the colon has a high rate of postoperative complications, which was associated with preoperative anti-TNF treatment in our study. Up to 30% of the patients with colonic CD did not receive input from the IBD MDT, whilst the use of minimally invasive surgery for surgical treatment of colonic CD ranges from 40 to 66% despite being beneficial for patients with a shorter LOS and reduced morbidity.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics statement
The study was approved by the ethics committee of every participating centre, and patients’ consent was obtained where required.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.
Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.
